Sumatriptan Tablet
Product Images NDC 70518-1184

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 70518-1184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy Label

This is a prescription medication containing 100mg of Sumatriptan in tablet form. It has a National Drug Code (NDC) of 70518-1184-00 and an expiration date and lot number that was not provided. The medication was manufactured by Aurohindo in Nagar, India. The packaging recommends keeping the medication out of reach of children and storing it at a temperature range of 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). Directions for use can be found on the package insert. The medication was repackaged by RemedyRepack in Indiana, PA.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

FDA Label Image

Sumatriptan Str

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.